GENEVA, Aug. 10 -- INNOLAKE BIOPHARMA (HANGZHOU) CO., LTD. (B 1003, NO.11, Lane 221, Dongyu Road, New Bund World Trade CenterPudong New Area, Shanghai 200126), 英诺湖医药(杭州)有限公司 (中国上海市浦东新区新区东育路221弄11号前滩世贸中心三期B栋1003单元) filed a patent application (PCT/CN2025/074146) for "MONOCLONAL ANTIBODY SPECIFICALLY BINDING TO PD-1 AND PHARMACEUTICAL USE THEREOF" on Jan 23, 2025. With publication no. WO/2025/162161, the details related to the patent application was published on Aug 07...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.